SEARCH:   Advanced

Blood, 1 March 2004, Vol. 103, No. 5, pp. 1779-1786. Prepublished online as a Blood First Edition Paper on November 6, 2003; DOI 10.1182/blood-2003-07-2260. This Article Full Text (PDF) All Versions of this Article: 2003-07-2260v1 103/5/1779    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Qu, X. Articles by Yamamura, H. Search for Related Content PubMed PubMed Citation Articles by Qu, X. Articles by Yamamura, H. Social Bookmarking                   What's this? Submitted July 8, 2003 Accepted October 31, 2003 Negative regulation of FcRI-mediated mast cell activation by a ubiquitin-protein ligase Cbl-b Xiujuan Qu, Kiyonao Sada*, Shinkou Kyo, Koichiro Maeno, S M Miah, and Hirohei Yamamura Department of Genome Sciences, Kobe University Graduate School of Medicine, Kobe, Japan * Corresponding author; email: ksada{at}med.kobe-u.ac.jp. Aggregation of the high-affinity IgE receptor (FcRI) on mast cells induces a number of biochemical events including protein-tyrosine phosphorylation leading to degranulation and multiple cytokine gene transcription. Here we have demonstrated that a second member of Cbl family of ubiquitin-protein ligase Cbl-b translocates into the lipid raft after FcRI engagement. Overexpression of Cbl-b in the lipid raft inhibits FcRI-mediated degranulation and cytokine gene transcription through the distinct mechanism. A point mutation of Cys373 in the RING finger domain of Cbl-b abrogates the suppression of FcRI-mediated degranulation, but not cytokine gene transcription. The antigen-induced tyrosine phosphorylation of FcRI, Syk, phospholipase C- (PLC-), activation of c-Jun N-terminal kinase (JNK), extracellular signal regulated kinase (ERK), inhibitor of nuclear factor B kinase (IKK), and Ca++ influx were all suppressed in the cells overexpressing Cbl-b in the lipid raft. In particular, the expression amount of Gab2 protein and thereby its FcRI-mediated tyrosine phosphorylation were dramatically down-regulated by ubiquitin-protein ligase activity of Cbl-b. These results suggest that Cbl-b is a negative regulator of both Lyn-Syk-LAT and Gab2-mediated complementary signaling pathways in FcRI-mediated mast cell activation. CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: U. Shukla, T. Hatani, K. Nakashima, K. Ogi, and K. Sada Tyrosine Phosphorylation of 3BP2 Regulates B Cell Receptor-mediated Activation of NFAT J. Biol. Chem., December 4, 2009; 284(49): 33719 - 33728. [Abstract] [Full Text] [PDF] B. M. Dale, D. Traum, H. Erdjument-Bromage, P. Tempst, and S. Greenberg Phagocytosis in Macrophages Lacking Cbl Reveals an Unsuspected Role for Fc{gamma} Receptor Signaling and Actin Assembly in Target Binding J. Immunol., May 1, 2009; 182(9): 5654 - 5662. [Abstract] [Full Text] [PDF] H. Peterfy, G. Toth, I. Pecht, and A. Erdei C3a-derived peptide binds to the type I Fc{varepsilon}R and inhibits proximal-coupling signal processes and cytokine secretion by mast cells Int. Immunol., October 1, 2008; 20(10): 1239 - 1245. [Abstract] [Full Text] [PDF] M. S. Czuczman, S. Olejniczak, A. Gowda, A. Kotowski, A. Binder, H. Kaur, J. Knight, P. Starostik, J. Deans, and F. J. Hernandez-Ilizaliturri Acquirement of Rituximab Resistance in Lymphoma Cell Lines Is Associated with Both Global CD20 Gene and Protein Down-Regulation Regulated at the Pretranscriptional and Posttranscriptional Levels Clin. Cancer Res., March 1, 2008; 14(5): 1561 - 1570. [Abstract] [Full Text] [PDF] G. Peruzzi, R. Molfetta, F. Gasparrini, L. Vian, S. Morrone, M. Piccoli, L. Frati, A. Santoni, and R. Paolini The Adaptor Molecule CIN85 Regulates Syk Tyrosine Kinase Level by Activating the Ubiquitin-Proteasome Degradation Pathway J. Immunol., August 15, 2007; 179(4): 2089 - 2096. [Abstract] [Full Text] [PDF] S. E. Gustin, C. B. F. Thien, and W. Y. Langdon Cbl-b Is a Negative Regulator of Inflammatory Cytokines Produced by IgE-Activated Mast Cells J. Immunol., November 1, 2006; 177(9): 5980 - 5989. [Abstract] [Full Text] [PDF] N. Kato, M. Nakanishi, and N. Hirashima Flotillin-1 Regulates IgE Receptor-Mediated Signaling in Rat Basophilic Leukemia (RBL-2H3) Cells J. Immunol., July 1, 2006; 177(1): 147 - 154. [Abstract] [Full Text] [PDF] Y. Peng, M. R. Power, B. Li, and T.-J. Lin Inhibition of IKK down-regulates antigen + IgE-induced TNF production by mast cells: a role for the IKK-I{kappa}B-NF-{kappa}B pathway in IgE-dependent mast cell activation J. Leukoc. Biol., June 1, 2005; 77(6): 975 - 983. [Abstract] [Full Text] [PDF] X. Qu, S. M. S. Miah, T. Hatani, M. Okazaki, N. Hori-Tamura, H. Yamamura, H. Hotta, and K. Sada Selective Inhibition of Fc{varepsilon}RI-Mediated Mast Cell Activation by a Truncated Variant of Cbl-b Related to the Rat Model of Type 1 Diabetes Mellitus J. Biochem., June 1, 2005; 137(6): 711 - 720. [Abstract] [Full Text] [PDF] B. J. Davis, B. F. Flanagan, A. M. Gilfillan, D. D. Metcalfe, and J. W. Coleman Nitric Oxide Inhibits IgE-Dependent Cytokine Production and Fos and Jun Activation in Mast Cells J. Immunol., December 1, 2004; 173(11): 6914 - 6920. [Abstract] [Full Text] [PDF] S. M. S. Miah, T. Hatani, X. Qu, H. Yamamura, and K. Sada Point mutations of 3BP2 identified in human-inherited disease cherubism result in the loss of function Genes Cells, November 1, 2004; 9(11): 993 - 1004. [Abstract] [Full Text] [PDF] J. Zhang, Y. J. Chiang, R. J. Hodes, and R. P. Siraganian Inactivation of c-Cbl or Cbl-b Differentially Affects Signaling from the High Affinity IgE Receptor J. Immunol., August 1, 2004; 173(3): 1811 - 1818. [Abstract] [Full Text] [PDF]

	Copyright © 2003 by American Society of Hematology         Online ISSN: 1528-0020